MALAT1 and prostate cancer: Linet al. [32] showed that thedownregulated or absent expression of MALAT1 is typical mostly of normaltissue, while MALAT1 overexpression is characteristic of breast, pancreatic,liver, lung, colorectal, and prostate cancers.